新加坡对电子烟设备中的埃托米达采取了严厉的措施; 马来西亚正在研究采取类似行动. Singapore cracks down on etomidate in vaping devices; Malaysia studies similar action.

新加坡正在采取措施打击依托咪酯在名为 Kpods 的电子烟设备中的滥用行为，根据《滥用药物法》将其列为 C 类药物。 Singapore is taking steps to crack down on the misuse of etomidate in vaping devices known as Kpods, by listing it as a Class C drug under the Misuse of Drugs Act. 此举使得可以采取更严格的执法和康复措施。 This move allows for tougher enforcement and rehabilitation measures. 同时,马来西亚正在考虑采取类似行动,根据滥用和相关风险的报告,特别是在青年使用者中,在可能将这种药物重新归类为危险药物之前,进行彻底研究。 Meanwhile, Malaysia is considering similar actions, conducting a thorough study before potentially reclassifying etomidate as a dangerous drug, following reports of its misuse and associated risks, particularly among young users.